GlucoTrack (NASDAQ:GCTK – Get Free Report) and AngioDynamics (NASDAQ:ANGO – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? Comparatively, 89.4% of AngioDynamics shares are held by institutional investors. 8.4% of GlucoTrack shares are held by company insiders. Analyst RatingsThis is a breakdown of recent ratings and price targets for GlucoTrack and AngioDynamics, as provided by MarketBeat.com. Given AngioDynamics’ stronger consensus rating and higher probable upside, analysts plainly believe AngioDynamics is more favorable than GlucoTrack.